Efficacy of raltegravir in achieving virological suppression at delivery in HIV-positive pregnant women: a systematic review and meta-analysis

Ying Zhang, Wenlin Wu, Mengru Yang, Jie Liu, Huanmei Wu, Yaokai Chen · 2025

Read Efficacy of raltegravir in achieving virological suppression at delivery in HIV-positive pregnant women: a systematic review and meta-analysis by Ying Zhang, Wenlin Wu, Mengru Yang, Jie Liu, Huanmei Wu, Yaokai Chen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12821861.txt.

Description

BackgroundThe world’s first HIV integrase inhibitor, raltegravir (RAL), has been widely used for the treatment of HIV infection over the past 15 years, and continues benefiting people living with HIV (PLWH) today due to its efficient virological suppression and favourable safety profile.

Catalog record

CREATORYing Zhang, Wenlin Wu, Mengru Yang, Jie Liu, Huanmei Wu, Yaokai Chen
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12821861

Browse the full library · About the Tower of Babel